The role of the PI3K signaling pathway in CD4+ T cell differentiation and function

被引:81
|
作者
Han, Jonathan M. [1 ]
Patterson, Scott J. [1 ]
Levings, Megan K. [1 ]
机构
[1] Univ British Columbia, Child & Family Res Inst, Dept Surg, Vancouver, BC V5Z 4H4, Canada
来源
FRONTIERS IN IMMUNOLOGY | 2012年 / 3卷
关键词
CD4(+) T cells; regulatory T cells; PI3K; AKT; FOXP3; mTOR; rapamycin; ACTIVATED PROTEIN-KINASE; GROWTH-FACTOR-BETA; PHOSPHATIDYLINOSITOL; 3-KINASE; FOXP3; EXPRESSION; CUTTING EDGE; MTOR KINASE; COSTIMULATION BLOCKADE; CYTOKINE PRODUCTION; CD28; COSTIMULATION; P110-DELTA ISOFORM;
D O I
10.3389/fimmu.2012.00245
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The relative activity of regulatory versus conventional CD4(+) T cells ultimately maintains the delicate balance between immune tolerance and inflammation. At the molecular level, the activity of phosphatidylinositol 3-kinase (PI3K) and its downstream positive and negative regulators has a major role in controlling the balance between immune regulation and activation of different subsets of effector CD4(+) T cells. In contrast to effector T cells which require activation of the PI3K to differentiate and mediate their effector function, regulatory T cells rely on minimal activation of this pathway to develop and maintain their characteristic phenotype, function, and metabolic state. In this review, we discuss the role of the PI3K signaling pathway in CD4(+) T cell differentiation and function, and focus on how modulation of this pathway in T cells can alter the outcome of an immune response, ultimately tipping the balance between tolerance and inflammation.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Role of PI3K/Akt signaling in memory 038 T cell differentiation
    Kim, Eui Ho
    Suresh, M.
    [J]. FRONTIERS IN IMMUNOLOGY, 2013, 4
  • [2] PI3-K p110δ has an important role in the differentiation and function of CD4+ T cells
    Patton, DT
    Emery, JL
    Rowan, WC
    Okkenhaug, K
    [J]. IMMUNOLOGY, 2005, 116 : 6 - 7
  • [3] The PI3K/AKT signaling pathway in regulatory T-cell development, stability, and function
    Pompura, Saige L.
    Dominguez-Villar, Margarita
    [J]. JOURNAL OF LEUKOCYTE BIOLOGY, 2018, 103 (06) : 1065 - 1076
  • [4] Critical roles of the PI3K/Akt signaling pathway in T cell development
    Juntilla, Marisa A.
    Koretzky, Guy A.
    [J]. IMMUNOLOGY LETTERS, 2008, 116 (02) : 104 - 110
  • [5] Role of class IA PI3K in regulatory T cell function
    Fujii, Hideki
    Matsuda, Satoshi
    Ohtani, Masashi
    Koyasu, Shigeo
    [J]. JOURNAL OF IMMUNOLOGY, 2012, 188
  • [6] Characterization of the function of p110 gamma PI3K in CD4+ lymphocytes
    Thomas, Molly
    Shimizu, Yoji
    [J]. JOURNAL OF IMMUNOLOGY, 2006, 176 : S200 - S200
  • [7] MicroRNA-126 regulates the induction and function of CD4+ Foxp3+ regulatory T cells through PI3K/AKT pathway
    Qin, Andong
    Wen, Zhenke
    Zhou, Ya
    Li, Ying
    Li, Yongju
    Luo, Junmin
    Ren, Tao
    Xu, Lin
    [J]. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2013, 17 (02) : 252 - 264
  • [8] Differential PI3Kδ Signaling in CD4+ T-cell Subsets Enables Selective Targeting of T Regulatory Cells to Enhance Cancer Immunotherapy
    Ahmad, Shamim
    Abu-Eid, Rasha
    Shrimali, Rajeev
    Webb, Mason
    Verma, Vivek
    Doroodchi, Atbin
    Berrong, Zuzana
    Samara, Raed
    Rodriguez, Paulo C.
    Mkrtichyan, Mikayel
    Khleif, Samir N.
    [J]. CANCER RESEARCH, 2017, 77 (08) : 1892 - 1904
  • [9] Chlamydia muridarum infection induces CD4+ T cells apoptosis via PI3K/AKT signal pathway
    Zheng, Ningbo
    Sun, Lida
    Pang, Gaoju
    Zha, Xiaoyu
    Niu, Wenhao
    Tan, Lu
    Zhang, Hong
    Bai, Hong
    [J]. PATHOGENS AND DISEASE, 2019, 77 (03):
  • [10] The PI3K/AKT/MTOR signaling pathway: The role of PI3K and AKT inhibitors in breast cancer
    Huemer F.
    Bartsch R.
    Gnant M.
    [J]. Current Breast Cancer Reports, 2014, 6 (2) : 59 - 70